Keywords: Alzheimer's Disease, Alzheimer's Disease
Motivation: Quantifying Aβ in patients with Alzheimer's disease poses a challenge due to the colocalization of Aβ accumulation and iron deposition.
Goal(s): Our goal was to simultaneously quantify Aβ and iron in ex-vivo human brains affected by AD.
Approach: We used a novel subvoxel QSM method to measure Aβ and iron levels. The gene transcriptomic profiles were further investigated using PLS and ontological analysis.
Results: Regions with higher diamagnetic and paramagnetic susceptibility were found higher levels of gene expression relating to the protein modification process and metal ion binding, as well as a relative abundance of exCA and glutamatergic neurons.
Impact: The quantification of diamagnetic and paramagnetic susceptibility via APART-QSM can offer valuable insights into regional-specific vulnerabilities in Alzheimer’s disease, particularly those related to Aβ aggregation and iron accumulation. This can aid clinicians to better find therapeutic targets.
This work was supported by the National Key R&D Program of China (2020AAA0109502), the National Key R&D Program of China (2021ZD0200500) , National Natural Science Foundation of China (82372036), the Fundamental Research Funds for the Central Universities (226-2023-00095),Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (CNLZD2001), Key Research Project of Zhejiang Lab (No. 2022ND0AC01).
We thank Lei Zhang, Peiran Jiang from the Core Facilities, Zhejiang University School of Medicine for their technical support.
1. Benilova I, Karran E, De Strooper B. The toxic Aβ oligomer and Alzheimer’s disease: An emperor in need of clothes. Nat Neurosci. 2012;15(3):349-357.
2. Becerril-Ortega J, Bordji K, Fréret T, Rush T, Buisson A. Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer’s disease. Neurobiol Aging. 2014;35(10):2288-2301.
3. Wärmländer SKTS, Österlund N, Wallin C, et al. Metal binding to the amyloid-β peptides in the presence of biomembranes: potential mechanisms of cell toxicity. J Biol Inorg Chem. 2019;24(8):1189-1196.
4. Gong NJ, Dibb R, Bulk M, van der Weerd L, Liu C. Imaging beta amyloid aggregation and iron accumulation in Alzheimer’s disease using quantitative susceptibility mapping MRI. Neuroimage. 2019;191(100):176-185.
5. Ahmed M, Chen J, Arani A, et al. The diamagnetic component map from quantitative susceptibility mapping (QSM) source separation reveals pathological alteration in Alzheimer’s disease-driven neurodegeneration. Neuroimage. 2023;280(January):120357.
6. Zhao Z, Zhang L, Wen Q, et al. The effect of beta-amyloid and tau protein aggregations on magnetic susceptibility of anterior hippocampal laminae in Alzheimer’s diseases. Neuroimage. 2021;244(July):118584.
7. Li Z, Feng R, Liu Q, et al. APART-QSM: An improved sub-voxel quantitative susceptibility mapping for susceptibility source separation using an iterative data fitting method. Neuroimage. 2023;274:120148.
8. Yao J, Tendler BC, Zhou Z, et al. Both noise‐floor and tissue compartment difference in diffusivity contribute to FA dependence on b‐value in diffusion MRI. Hum Brain Mapp. 2023;44(4):1371-1388.
9. Glasser MF, Coalson TS, Robinson EC, et al. A multi-modal parcellation of human cerebral cortex. Nature. 2016;536(7615):171-178.
10. Avants BB, Tustison N, Song G. Advanced Normalization Tools ( ANTS ). 2009:1-29.
11. Thomas GEC, Zarkali A, Ryten M, et al. Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease. Brain. 2021;144(6):1787-1798.
12. Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012;489(7416):391-399.
13. Markello RD, Arnatkeviciute A, Poline J-B, Fulcher BD, Fornito A, Misic B. Standardizing workflows in imaging transcriptomics with the abagen toolbox. Elife. 2021;10.
14. Raudvere U, Kolberg L, Kuzmin I, et al. G:Profiler: A web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019;47(W1):W191-W198.
15. Skene NG, Grant SGN. Identification of vulnerable cell types in major brain disorders using single cell transcriptomes and expression weighted cell type enrichment. Front Neurosci. 2016;10(JAN):1-11.
16. Carr, R. M., Oranu, A., & Khungar V, Pengse Po1, Erin Delaney1, Howard Gamper2, Miklos Szanti-Kis3, Lee Speight3, LiWei Tu1, Andrey Kosolapov1, E. James Petersson3, Ya-Ming Hou2 and CD. Canonical Genetic Signatures of the Adult Human Brain Michael. Physiol Behav. 2016;176(1):139-148.
17. Habib N, Avraham-Davidi I, Basu A, et al. Massively parallel single-nucleus RNA-seq with DroNc-seq. Nat Methods. 2017;14(10):955-958.
18. Qiu W, Zhang H, Bao A, Zhu K, Huang Y. Standardized Operational Protocol for Human Brain Banking in China. Neurosci Bull. 2019;35(2):270-276.
19. Van Bergen JMG, Li X, Quevenco FC, et al. Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age. Neuroimage. 2018;174(February):308-316.
20. Butterfield DA, Reed T, Newman SF, Sultana R. Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer’s disease and mild cognitive impairment. Free Radic Biol Med. 2007;43(5):658-677.
21. Hagemeier J, Geurts JJG, Zivadinov R. Brain iron accumulation in aging and neurodegenerative disorders. Expert Rev Neurother. 2012;12(12):1467-1480.
22. Counts SE, Alldred MJ, Che S, Ginsberg SD, Mufson EJ. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology. 2014;79:172-179.
23. Greenamyre JT, Maragos WF, Albin RL, Penney JB, Young AB. Glutamate transmission and toxicity in alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(4):421-430.
24. Vazin T, Ball KA, Lu H, et al. Efficient derivation of cortical glutamatergic neurons from human pluripotent stem cells: A model system to study neurotoxicity in Alzheimer’s disease. Neurobiol Dis. 2014;62:62-72.